Form 4 for CYRX Cryoport, Inc.
Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-09 · accession 0001104659-22-032997 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-11 | 2022-03-09 | CYRX | Sawicki Mark W | CSO | M - OptEx | $0.00 | +2,667 | 52.8K | +5% | $0 |
| D | 2022-03-11 | 2022-03-09 | CYRX | Sawicki Mark W | CSO | S - Sale+OE | $31.05 | -1,410 | 51.4K | -3% | -$43.8K |
| D | 2022-03-11 | 2022-03-09 | CYRX | Sawicki Mark W | CSO | M - OptEx | $0.00 | -2,667 | 8,000 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-09 | M | A | 2,667 | $0.00 | 52,796 | D | — | — | (F1) Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. |
| 2 | Common | Common Stock | 2022-03-09 | S | D | 1,410 | $31.05 | 51,386 | D | — | — | |
| 3 | Derivative | Restricted Stock Rights | 2022-03-09 | M | D | 2,667 | $0.00 | 8,000 | D | — · — to — | 2,667 Common Stock | (F3) The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022. |